Akebia Therapeutics | AKBA - Ebitda



金融业
股票价格
USD 0.45
资产
USD 342.13M
现金及等价物
USD 159.25M
销售成本
USD 10.34M
流动资产
USD 220.79M
流动负债
USD 162.35M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 20.37M
销售毛利
USD 47.28M
债务利息支出
342.13M
贷款资金
USD 12.78M
市值
USD 145.5M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 18.7M
贸易债权人
USD 7.61M
应收帐款人
USD 47.03M


Ebitda 更改 日
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Ardelyx USD -9.78M 19.98M 2026-06
Astellas Pharma JPY 182.02B 53.22B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Celltrion KRW 25.72B 6.08B 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -61.38M 14.92M 2026-06
Exelixis USD 275.36M 19.96M 2026-09
Fresenius Medical Care EUR 817M 26.66M 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.99B 721M 2026-06
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD 15.45M 20.21M 2026-06
Pharma Mar EUR 9.63M 8.93M 2026-09
Prothena USD -18.49M 44.46M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Qiagen NV USD 219.78M 12.13M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sarepta Therapeutics USD 30.17M 345.31M 2026-06
Sartorius EUR 279.9M 600K 2026-09
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M 2026-06